Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
anti-CD133-CAR vector-transduced T cells
Chinese PLA General Hospital
Liver Cancer
1 trial -
anti-CD7 CAR-pNK cells
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
anti-FLT3 CAR-T
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
anti-MUC1 CAR-pNK cells
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
artesunate
Hospital Authority, Hong Kong
Colorectal Cancer
1 trial -
asparaginase Erwinia chrysanthemi
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia
1 trial -
auranofin
Ultragenyx UK Limited
Chronic Lymphocytic Leukemia (CLL)
1 trial -
autologous dendritic cells pulsed with tumor lysate antigen Vaccine
NORTHWEST BIOTHERAPEUTICS INC
Giant Cell Glioblastoma
1 trial -
avelumab
Nektar Therapeutics UK Limited
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
1 trial -
avelumab
Samsung Bioepis NL B.V.
Lymphoma, Extranodal NK-T-Cell
1 trial -
avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Metastatic Cancer
1 trial -
azenosertib
Zentalis Pharmaceuticals
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
1 trial -
befotertinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC (Non-small Cell Lung Cancer)
1 trial -
bendamustine
Teva Pharma GmbH
Hodgkin Lymphoma
2 trials -
bendamustine and rituximab
Teva Pharma GmbH
Non-Hodgkin's Lymphoma
1 trial -
bevacizumab
United Therapeutics Europe Ltd
Colorectal Cancer
1 trial -
bevacizumab [Avastin]
Hoffmann-La Roche
Liver Cancer
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Breast Cancer
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Cutaneous T-Cell Lymphoma
1 trial -
biricodar dicitrate
Vertex Pharmaceuticals (Australia) Pty.
Lung Cancer
1 trial -
bleomycin sulfate
Children's Hospital of Fudan University
Childhood Germ Cell Tumor
1 trial -
cRGD-ZW800-1
Disc Medicine
Oral cancer
1 trial -
cRGD-ZW800-1
Disc Medicine
Squamous cell carcinoma of the larynx and hypopharynx
1 trial -
cadonilimab combined +paclitaxel (albumin-bound)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Adenocarcinoma
1 trial -
cadonilizumab combined with neoadjuvant radiochemotherapy
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
capecitabine
Cardiff Oncology
Pancreatic Cancer
1 trial -
carboplatin
Cardiff Oncology
Bladder Cancer
1 trial -
cardonilizumab combined with renvastinib
The First People's Hospital of Lianyungang
Resectable Clear Cell Carcinoma of the Kidney
1 trial -
cemacabtagene ansegedleucel
Allogene Therapeutics
Large B-cell Lymphoma
1 trial -
cemiplimab
Regeneron UK Limited
Cutaneous Basal Cell Carcinoma
1 trial -
cemiplimab
Regeneron UK Limited
Melanoma
1 trial -
cemiplimab
Regeneron UK Limited
Advanced Cutaneous Squamous Cell Carcinoma
1 trial -
cemiplimab
Regeneron UK Limited
Carcinoma, Basal Cell
1 trial -
cemiplimab (monotherapy)
Regeneron UK Limited
Relapsed Solid Tumor
1 trial -
certepetide
LISATA THERAPEUTICS, INC.
Cholangiocarcinoma
1 trial -
certepetide
LISATA THERAPEUTICS, INC.
Pancreas Cancer
1 trial -
cetrelimab, JNJ-63723283
Janssen-Cilag International N.V.
Advanced Stage Solid Tumors
1 trial -
cetuximab (Erbitux)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Cancer
1 trial -
chemotherapy: TS-1, Leucovorin and Gemcitabine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatic Adenocarcinoma
1 trial -
chidamide + camrelizumab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
chidamide，fulvestrant
The First People's Hospital of Lianyungang
Hormone Receptor-positive Advanced Breast Cancer
1 trial -
cisplatin
Cardiff Oncology
Bladder Cancer
2 trials -
cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma
1 trial -
cisplatin and 5-Fu combined with nimotuzumab
The First People's Hospital of Lianyungang
Stage IV Nasopharyngeal Carcinoma
1 trial -
combination with Disitamab Vedotin and with Tislelizumab and Capecitabine
Hospital Authority, Hong Kong
Gastric Cancer
1 trial -
cytarabine
Teva Pharma GmbH
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
1 trial -
delolimogene mupadenorepvec
Chongqing Precision Biotech Co., Ltd
Malignant Melanoma
1 trial -
disitamab vedotin
Pfizer
Urothelial Carcinoma
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.